Reply to “HDAC2 deficiency and histone acetylation”

被引：0
作者：
Santiago Ropero
Manel Esteller
机构：
[1] Cancer Epigenetics Group,
[2] Spanish National Cancer Research Centre,undefined
来源：
Nature Genetics | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：813 / 813
相关论文
共 50 条
[31]   Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo [J].
R. D. W. Kelly ;
A. Chandru ;
P. J. Watson ;
Y. Song ;
M. Blades ;
N. S. Robertson ;
A. G. Jamieson ;
J. W. R. Schwabe ;
S. M. Cowley .
Scientific Reports, 8
[32]   The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 [J].
Krämer, OH ;
Zhu, P ;
Ostendorff, HP ;
Golebiewski, M ;
Tiefenbach, J ;
Peters, MA ;
Brill, B ;
Groner, B ;
Bach, I ;
Heinzel, T ;
Göttlicher, M .
EMBO JOURNAL, 2003, 22 (13) :3411-3420
[33]   Design (Docking and QSAR Studies) and synthesis of histone deacetylase 2 (HDAC2) inhibitors series [J].
Heidy Martínez-Pacheco ;
Judith Espinosa-Raya ;
Ofir Picazo ;
Gabriel Roldán-Roldán ;
Omar Viñas-Bravo ;
Guillermo Ramírez-Galicia .
Medicinal Chemistry Research, 2018, 27 :206-223
[34]   Hdac2 Modulates Atherosclerosis [J].
Pandey, Deepesh ;
Hori, Daijiro ;
Nomura, Yohei ;
Bhatta, Anil ;
Berkowitz, Dan ;
Romer, Lew .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
[35]   Design (Docking and QSAR Studies) and synthesis of histone deacetylase 2 (HDAC2) inhibitors series [J].
Martinez-Pacheco, Heidy ;
Espinosa-Raya, Judith ;
Picazo, Ofir ;
Roldan-Roldan, Gabriel ;
Vinas-Bravo, Omar ;
Ramirez-Galicia, Guillermo .
MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (01) :206-223
[36]   Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients [J].
Tan, Chunting ;
Xuan, Lingling ;
Cao, Shuhua ;
Yu, Ganggang ;
Hou, Qi ;
Wang, Haoyan .
PLOS ONE, 2016, 11 (01)
[37]   A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition [J].
Ropero, S ;
Fraga, MF ;
Ballestar, E ;
Hamelin, R ;
Yamamoto, H ;
Boix-Chornet, M ;
Caballero, R ;
Alaminos, M ;
Setien, F ;
Paz, MF ;
Herranz, M ;
Palacios, J ;
Arango, D ;
Orntoft, TF ;
Aaltonen, LA ;
Schwartz, S ;
Esteller, M .
NATURE GENETICS, 2006, 38 (05) :566-569
[38]   A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition [J].
Santiago Ropero ;
Mario F Fraga ;
Esteban Ballestar ;
Richard Hamelin ;
Hiroyuki Yamamoto ;
Manuel Boix-Chornet ;
Rosalia Caballero ;
Miguel Alaminos ;
Fernando Setien ;
Maria F Paz ;
Michel Herranz ;
Jose Palacios ;
Diego Arango ;
Torben F Orntoft ;
Lauri A Aaltonen ;
Simó Schwartz ;
Manel Esteller .
Nature Genetics, 2006, 38 :566-569
[39]   Host histone acetylation unlocks HDAC inhibitor potential [J].
Terranova-Barberio, Manuela ;
Thomas, Scott ;
Munster, Pamela N. .
ONCOTARGET, 2017, 8 (63) :106161-106162
[40]   Selective inhibition of HDAC1 and HDAC2 counteracts medulloblastoma cell growth in mouse models through Gli acetylation [J].
Coni, S. ;
Mancuso, A. B. ;
Di Magno, L. ;
Sdruscia, G. ;
Rotili, D. ;
Mai, A. ;
Canettieri, G. .
EUROPEAN JOURNAL OF CANCER, 2016, 61 :S143-S144
12345